Literature DB >> 15748263

Should we screen Eastern Mediterranean sickle beta-thalassemia patients for inherited thrombophilia?

Z K Otrock, R A R Mahfouz, A T Taher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15748263     DOI： 10.1111/j.1538-7836.2005.01148.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients.

Authors:  Hussain Isma'eel; M S Arnaout; Wael Shamseddeen; R Mahfouz; N Zeineh; Oussama Jradi; Ali Taher
Journal:  J Thromb Thrombolysis       Date:  2006-10       Impact factor: 2.300

Review 2.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

3.  Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.

Authors:  Zohreh Rahimi; Asad Vaisi-Raygani; Ronald L Nagel; Adriana Muniz
Journal:  J Thromb Thrombolysis       Date:  2007-07-11       Impact factor: 2.300

4.  Sickle cell disease and venous thromboembolism.

Authors:  Zohreh Rahimi; Abbas Parsian
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.